Companies
Vertex Pharmaceuticals (Europe) Ltd
This profile is still being built. It is not yet listed in the company index.
MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.
Timeline
30 Oct 2026
MHRA extends Casgevy approval to children aged five and over with sickle cell disease and β-thalassaemia
Source: MHRA